LeBel M, Vallée F, St-Laurent M
Laboratoire de Pharmacocinétique Clinique, Ecole de Pharmacie, Université Laval, Quebec, Canada.
Antimicrob Agents Chemother. 1990 Jun;34(6):1254-6. doi: 10.1128/AAC.34.6.1254.
The effect of multiple doses of lomefloxacin (400 mg twice a day) on the clearance of theophylline and the urinary excretion of its metabolites was investigated in 15 healthy male subjects. Concentrations of theophylline in plasma were measured by TDx (Abbott Diagnostics, Mississauga, Ontario, Canada). Urinary excretion of theophylline and its three major metabolites and lomefloxacin in plasma were assayed by high-performance liquid chromatography. Total theophylline clearance remained unchanged before lomefloxacin treatment and after lomefloxacin single- and multiple-dose treatments (58.02, 56.57, 54.07 ml/min, respectively). The urinary recovery of unchanged theophylline and its major metabolites stayed stable during the study. We conclude that lomefloxacin can be added to the list of fluoroquinolones that can be administered safely with theophylline.
在15名健康男性受试者中研究了多次服用洛美沙星(每日两次,每次400毫克)对茶碱清除率及其代谢产物尿排泄的影响。采用TDx(加拿大安大略省密西沙加市雅培诊断公司)测定血浆中的茶碱浓度。通过高效液相色谱法测定血浆中茶碱及其三种主要代谢产物以及洛美沙星的尿排泄情况。在洛美沙星治疗前、单剂量和多剂量治疗后,总茶碱清除率保持不变(分别为58.02、56.57、54.07毫升/分钟)。在研究期间,未改变的茶碱及其主要代谢产物的尿回收率保持稳定。我们得出结论,洛美沙星可添加到可与茶碱安全联用的氟喹诺酮类药物清单中。